Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58,752 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early course of newly diagnosed moderate-to-severe ulcerative colitis in Korea: Results from a hospital-based inception cohort study (MOSAIK).
Yoon JY, Cha JM, Lee CK, Park YS, Huh KC, Shin JE, Kim YS, Eun CS, Yoon SM, Cheon JH, Park YS, Ye BD, Lee Y, Kim Y, Kim HJ; MOSAIK study group of the Korean Association for the Study of Intestinal Diseases (KASID). Yoon JY, et al. Among authors: lee y, lee ck. J Gastroenterol Hepatol. 2021 Aug;36(8):2149-2156. doi: 10.1111/jgh.15435. Epub 2021 Feb 20. J Gastroenterol Hepatol. 2021. PMID: 33555067
Clinical outcomes in adult patients with plaque psoriasis treated with ustekinumab under real-world practice in Korea: A prospective, observational, multi-center, postmarketing surveillance study.
Youn SW, Yu DY, Kim BS, Kim Y, Kim KJ, Choi JH, Son SW, Lee ES, Ro YS, Park YL, Lee Y, Lee JH, Park HJ, Kim TY, Lee MG, Shin MK, Choi GS, Kim DH, Jo SJ, Lee SC; Stelara PMS investigators. Youn SW, et al. Among authors: lee y, lee mg, lee es, lee jh, lee sc. J Dermatol. 2021 Jun;48(6):778-785. doi: 10.1111/1346-8138.15670. Epub 2021 Feb 2. J Dermatol. 2021. PMID: 33528054
Differences in Clinical Responses to Ustekinumab Treatment among Body Regions: Results from a Real-World Prospective, Observational, and Multi-Center Study in Korea.
Son SW, Yu DY, Kim Y, Ahn HH, Jang YH, Roh JY, Lee YB, Lee JY, Kim MH, Lee Y, Park GH, Yoon HS, Youn SW; Stelara PMS investigators. Son SW, et al. Among authors: lee yb, lee y, lee jy. Ann Dermatol. 2022 Feb;34(1):14-21. doi: 10.5021/ad.2022.34.1.14. Epub 2022 Jan 27. Ann Dermatol. 2022. PMID: 35221590 Free PMC article.
Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator-controlled VOYAGE 1/2 trials.
Youn SW, Yu DY, Kim TY, Kim BS, Lee SC, Lee JH, Choe YB, Lee JH, Choi JH, Roh JY, Jo SJ, Lee ES, Shin MK, Lee MG, Jiang J, Lee Y. Youn SW, et al. Among authors: lee y, lee mg, lee jh, lee es, lee sc. J Dermatolog Treat. 2022 Feb;33(1):535-541. doi: 10.1080/09546634.2020.1770174. Epub 2020 May 27. J Dermatolog Treat. 2022. PMID: 32419536 Clinical Trial.
58,752 results
You have reached the last available page of results. Please see the User Guide for more information.